Author:
Edition: 2012
Publisher: Springer
Binding: Hardcover
ISBN: 303480217X
Twenty Years of G-CSF: Clinical and Nonclinical Discoveries (Milestones in Drug Therapy)
Granulocyte colony-stimulating factor (G-CSF or GCSF) is a secreted glycoprotein that stimulates the proliferation and differentiation of granulocyte precursor cells, and induces mobilization of peripheral blood progenitor cells from the bone marrow. Medical books Twenty Years of G-CSF. Medical books Twenty Years Of G-csf: Clinical And Nonclinical Discoveries Molineux, Graham (ed. format hardback language english publication year 07 01 2012 series milestones in drug therapy subject medicine subject 2 clinical medicine professional title twenty years of g csf clinical and nonclinical discoveries author molineux graham editor foote maryann editor arvedson tara editor publisher springer verlag publication date jan 31 2012 pages 471 binding hardcover edition 1 st dimensions 6 25 wx 9 25 hx 1 25 d isbn 303480217 x subject medical pharmacology description granulocyte colony s
Download link for Twenty Years of G-CSF
format hardback language english publication year 07 01 2012 series milestones in drug therapy subject medicine subject 2 clinical medicine professional title twenty years of g csf clinical and nonclinical discoveries author molineux graham editor foote maryann editor arvedson tara editor publisher springer verlag publication date jan 31 2012 pages 471 binding hardcover edition 1 st dimensions 6 25 wx 9 25 hx 1 25 d isbn 303480217 x subject medical pharmacology description granulocyte colony s
Store Search search Title, ISBN and Author Twenty Years of G-CSF: Clinical and Nonclinical Discoveries Estimated delivery 3-12 business days Format Hardcover Condition Brand New This volume in the Milestones in Drug Therapy series describes the past 20 years of treatment with recombinant human G-CSF, including basic science, the use of G-CSF in both the oncology and non-oncology settings, and the safety and economics of its use. Publisher Description Granulocyte colony-stimulating factor (G-CSF
Granulocyte colony-stimulating factor (G-CSF or GCSF) is a secreted glycoprotein that stimulates the proliferation and differentiation of granulocyte precursor cells, and induces mobilization of peripheral blood progenitor cells from the bone marrow. Development of recombinant human G-CSF has had a profound impact on the treatment of many diseases, including severe chronic neutropenia and cancer, and has enabled peripheral stem cell transplantation to supplant bone marrow transplantation in the autologous setting.
This Milestones in Drug Therapy volume describes the experience of the last 20 y
This Milestones in Drug Therapy volume describes the experience of the last 20 y
"Granulocyte colony-stimulating factor (G-CSF or GCSF) is a secreted glycoprotein that stimulates the proliferation and differentiation of granulocyte precursor cells, and induces mobilization of peripheral blood progenitor cells from the bone marrow. Development of recombinant human G-CSF has had a profound impact on the treatment of many diseases, including severe chronic neutropenia and cancer, and has enabled peripheral stem cell transplantation to supplant bone marrow transplantation in the autologous setting. This Milestones in Drug Therapy volume describes the experience of the last 20
Medical Book Twenty Years of G-CSF
Development of recombinant human G-CSF has had a profound impact on the treatment of many diseases, including severe chronic neutropenia and cancer, and has enabled peripheral stem cell transplantation to supplant bone marrow transplantation in the autologous setting. This Milestones in Drug Therapy volume describes the experience of the last 20 years of treatment with recombinant human G-CSF, including the basic science, the use of recombinant human G-CSF in both the oncology and nononcology settings, and the safety and economics of its use. Many of the authors were the original investigators of recombinant human G-CSF and other authors are key researchers who provide their outlook for the next 20 years for use of and research with recombinant human G-CSF.